Wednesday, 27 April 2016

Cardiac Rhythm Management Devices Market Forecast 2007-2021 United States

Summary
GlobalData’s new report, "United States Cardiac Rhythm Management Devices Market Outlook to 2021", provides key market data on the United States Cardiac Rhythm Management Devices market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.
The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.
The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.
The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.
Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.


Scope
- Market size for Cardiac Rhythm Management Devices market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Cardiac Rhythm Management Devices market.
- Global corporate-level profiles of key companies operating within the United States Cardiac Rhythm Management Devices market.
- Key players covered include Medtronic plc, St. Jude Medical, Inc., Boston Scientific Corporation, Biotronik SE & Co. KG and Others.
Reasons to buy
- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.


Table of Contents
1 Table of Contents 2
    1.1 List of Tables 6
    1.2 List of Figures 7
2 Introduction 8
    2.1 What Is This Report About? 8
    2.2 Cardiac Rhythm Management Devices Market Segmentation 8
    2.3 Definitions of Markets Covered in the Report 9
3 Cardiac Rhythm Management Devices Market, United States 11
    3.1 Cardiac Rhythm Management Devices Market, United States, Revenue ($m), 2007-2014 11
    3.2 Cardiac Rhythm Management Devices Market, United States, Revenue ($m), 2014-2021 13
      3.2.1 Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), by Segment, 2007-2014 15
      3.2.2 Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), by Segment, 2007-2014 17
      3.2.3 Pacemakers Market, United States, Revenue ($m), by Segment, 2007-2014 19
      3.2.4 Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), by Segment, 2014-2021 21
      3.2.5 Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), by Segment, 2014-2021 23
      3.2.6 Pacemakers Market, United States, Revenue ($m), by Segment, 2014-2021 25
    3.3 Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2007-2014 27
    3.4 Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2014-2021 29
      3.4.1 Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), by Segment, 2007-2014 31
      3.4.2 Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), by Segment, 2007-2014 33
      3.4.3 Pacemakers Market, United States, Volume (Units), by Segment, 2007-2014 35
      3.4.4 Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), by Segment, 2014-2021 37 

 

     3.4.5 Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), by Segment, 2014-2021 39
      3.4.6 Pacemakers Market, United States, Volume (Units), by Segment, 2014-2021 41
    3.5 Cardiac Rhythm Management Devices Market, United States, Average Price ($), 2007-2021 43
    3.6 Cardiac Rhythm Management Devices Market, United States, Distribution Share by Revenue ($m), 2013-2014 45
    3.7 Cardiac Rhythm Management Devices Market, United States, Company Share by Revenue ($m), 2014 46
4 Overview of Key Companies in United States, Cardiac Rhythm Management Devices Market 48
    4.1 Medtronic plc 48
      4.1.1 Company Overview 48
    4.2 St. Jude Medical, Inc. 48
      4.2.1 Company Overview 48
    4.3 Boston Scientific Corporation 48
      4.3.1 Company Overview 48
    4.4 Biotronik SE & Co. KG 49 


      4.4.1 Company Overview 49
5 Cardiac Rhythm Management Devices Market Pipeline Products 50
6 Financial Deals Landscape 51
    6.1 Equity Offerings 51
      6.1.1 Ventripoint Diagnostics to Raise up to USD0.3 Million in Private Placement of Units 51
      6.1.2 Ventripoint Diagnostics Raises USD2.3 Million in Private Placement of Units 53
    6.2 Venture Financing 55
      6.2.1 EBR Systems Raises USD20 Million in Venture Financing
55 


Contact US:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)


No comments:

Post a Comment